Short answer · Medically reviewed summary · Last updated: 2026-04-07
Wolfram Syndrome is classified under the ICD-10 code E13.8 (Other specified diabetes mellitus with other specified complications) and the ICD-9 code 250.80 (Diabetes with other specified manifestations). Because Wolfram Syndrome is a rare, progressive neurodegenerative disorder, these codes are used for administrative and billing purposes to reflect the primary clinical manifestation of diabetes mellitus associated with the condition. What is the clinical significance of Wolfram Syndrome? Wolfram Syndrome, often referred to by the acronym DIDMOAD (Diabetes Insipidus, Diabetes Mellitus, Optic Atrophy, and Deafness), is a rare genetic disorder characterized by the progressive loss of function in various organ systems.
Wolfram Syndrome is classified under the ICD-10 code E13.8 (Other specified diabetes mellitus with other specified complications) and the ICD-9 code 250.80 (Diabetes with other specified manifestations). Because Wolfram Syndrome is a rare, progressive neurodegenerative disorder, these codes are used for administrative and billing purposes to reflect the primary clinical manifestation of diabetes mellitus associated with the condition.
Wolfram Syndrome, often referred to by the acronym DIDMOAD (Diabetes Insipidus, Diabetes Mellitus, Optic Atrophy, and Deafness), is a rare genetic disorder characterized by the progressive loss of function in various organ systems. While the ICD-10 and ICD-9 codes focus on the diabetic component, the disease is far more complex. It typically presents in childhood with insulin-dependent diabetes mellitus, followed by progressive optic nerve atrophy that leads to significant vision loss. Understanding that Wolfram Syndrome affects the endoplasmic reticulum of cells helps patients and caregivers grasp why symptoms are so multisystemic and progressive.
Yes, Wolfram Syndrome is an autosomal recessive disorder, meaning an individual must inherit two copies of the mutated gene—one from each parent—to manifest the disease. The primary gene associated with the condition is WFS1, which provides instructions for making a protein called wolframin. In our community at DiseaseMaps.org, where 59 people with Wolfram Syndrome have shared their experiences, we see firsthand the impact of this genetic inheritance on families. Genetic counseling is highly recommended for families planning to have children to understand the 25% recurrence risk associated with this pattern.
Diagnosis is based on a combination of clinical findings and molecular genetic testing. Physicians look for specific patterns of development to confirm Wolfram Syndrome, as early diagnosis is critical for managing the multisystemic nature of the disorder. Diagnostic markers include:
Because there is currently no cure for Wolfram Syndrome, management is focused on supportive care and the treatment of individual symptoms. A multidisciplinary team is essential. This often involves endocrinologists to manage blood glucose levels, ophthalmologists to monitor vision, and neurologists to address potential brainstem atrophy or psychiatric complications. Clinical trials are currently investigating potential neuroprotective therapies aimed at slowing the underlying cellular pathology of Wolfram Syndrome, offering hope for future breakthroughs in treatment.
Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.